The Real-World Characteristics and Outcomes of Newly Diagnosed Myeloma Patients Ineligible for Clinical Trials

被引：8
|
作者：
Fiala, Mark [1 ]
Dukeman, James [1 ]
Stockerl-Goldstein, Keith [1 ]
Tomasson, Michael [2 ]
Wildes, Tanya [1 ]
Vij, Ravi [1 ]
机构：
[1] Washington Univ, Sch Med, St Louis, MO USA
[2] Univ Iowa, Carver Coll Med, Iowa City, IA 52242 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2017年 / 17卷 / 01期
关键词：
D O I：
10.1016/j.clml.2017.03.101
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PS-099
引用
收藏
页码：E55 / E56
页数：2
相关论文
共 50 条
  • [11] A glimpse into transplant-ineligible newly diagnosed multiple myeloma treatment in real-world practice in Spain: carinae study
    de Arriba de la Fuente, Felipe
    Hernandez Garcia, Miguel Teodoro
    Soler Campos, Juan Alfons
    Herraez Rodriguez, Susana
    Jose Moreno, Ma
    Conzalez Pardo, Miriam
    Gironella Mesa, Mercedes
    Casanova Espinosa, Maria
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S143 - S144
  • [12] Real-world treatment patterns for patients with newly diagnosed multiple myeloma in Alberta, Canada
    Jimenez-Zepeda, Victor H.
    Chen, Guanmin
    Shaw, Eileen
    Farris, Megan S.
    Cowling, Tara
    Tay, Jason
    [J]. LEUKEMIA & LYMPHOMA, 2022, 63 (11) : 2557 - 2564
  • [13] Unravelling Transplant-Ineligible Newly Diagnosed Multiple Myeloma Treatment in Real-World Practice in Spain. Carinae Study
    Casanova Espinosa, Maria
    Hernandez Garcia, Miguel Teodoro
    Soler Campos, Juan Alfonso
    Hernandez Rodriguez, Susana
    Moreno Belmonte, Maria Jose
    Gonzalez Pardo, Miriam Concepcion
    Gironella Mesa, Mercedes
    de Arriba de la Fuente, Felipe
    [J]. BLOOD, 2023, 142
  • [14] Clinical Outcomes and Serum B-Cell Maturation Antigen Levels in a Real-World Unselected Population of Newly Diagnosed Multiple Myeloma Patients
    Jew, Scott
    Bujarski, Sean
    Regidor, Bernard
    Emamy-Sadr, Marsiye
    Swift, Regina
    Eades, Benjamin
    Kim, Susanna
    Eshaghian, Shahrooz
    Berenson, James R.
    [J]. TARGETED ONCOLOGY, 2023, 18 (05) : 735 - 747
  • [15] Clinical Outcomes and Serum B-Cell Maturation Antigen Levels in a Real-World Unselected Population of Newly Diagnosed Multiple Myeloma Patients
    Scott Jew
    Sean Bujarski
    Bernard Regidor
    Marsiye Emamy-Sadr
    Regina Swift
    Benjamin Eades
    Susanna Kim
    Shahrooz Eshaghian
    James R. Berenson
    [J]. Targeted Oncology, 2023, 18 : 735 - 747
  • [16] Real-world data on induction therapy in patients with transplant-ineligible newly diagnosed multiple myeloma: retrospective analysis of 598 cases from Kansai Myeloma Forum
    Shimura, Yuji
    Shibayama, Hirohiko
    Nakaya, Aya
    Yamamura, Ryosuke
    Imada, Kazunori
    Kaneko, Hitomi
    Hanamoto, Hitoshi
    Fuchida, Shin-ichi
    Tanaka, Hirokazu
    Kosugi, Satoru
    Kiyota, Miki
    Matsui, Toshimitsu
    Kanda, Junya
    Iida, Masato
    Matsuda, Mitsuhiro
    Uoshima, Nobuhiko
    Shibano, Masaru
    Karasuno, Takahiro
    Hamada, Tsuneyoshi
    Ohta, Kensuke
    Ito, Tomoki
    Yagi, Hideo
    Yoshihara, Satoshi
    Shimazaki, Chihiro
    Nomura, Shosaku
    Hino, Masayuki
    Takaori-Kondo, Akifumi
    Matsumura, Itaru
    Kanakura, Yuzuru
    Kuroda, Junya
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 118 (05) : 609 - 617
  • [17] Real-World Clinical Burden of Newly Diagnosed Heart failure in Thai Patients
    Boonyapiphat, Thanita
    Tangkittikasem, Thidaporn
    Torpongpun, Artit
    Senthong, Vichai
    Jiampo, Panyapat
    [J]. CARDIOLOGY AND THERAPY, 2024, 13 (02) : 415 - 430
  • [18] Real-world data on induction therapy in patients with transplant-ineligible newly diagnosed multiple myeloma: retrospective analysis of 598 cases from Kansai Myeloma Forum
    Yuji Shimura
    Hirohiko Shibayama
    Aya Nakaya
    Ryosuke Yamamura
    Kazunori Imada
    Hitomi Kaneko
    Hitoshi Hanamoto
    Shin-ichi Fuchida
    Hirokazu Tanaka
    Satoru Kosugi
    Miki Kiyota
    Toshimitsu Matsui
    Junya Kanda
    Masato Iida
    Mitsuhiro Matsuda
    Nobuhiko Uoshima
    Masaru Shibano
    Takahiro Karasuno
    Tsuneyoshi Hamada
    Kensuke Ohta
    Tomoki Ito
    Hideo Yagi
    Satoshi Yoshihara
    Chihiro Shimazaki
    Shosaku Nomura
    Masayuki Hino
    Akifumi Takaori-Kondo
    Itaru Matsumura
    Yuzuru Kanakura
    Junya Kuroda
    [J]. International Journal of Hematology, 2023, 118 : 609 - 617
  • [19] Real-World Treatment Characteristics and Clinical Outcomes in Medicare Beneficiaries With Newly Diagnosed Multiple Myeloma (NDMM) Treated With Bortezomib in Combination With Lenalidomide and Dexamethasone (VRd)
    Richter, Joshua
    Latremouille-Viau, Dominick
    Saunders, Eleanor
    Lin, Peggy L.
    Tekle, Christina
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S420 - S420
  • [20] ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA IN THE REAL WORLD
    Yamazaki, E.
    Takahashi, H.
    Ishibashi, D.
    Kishimoto, K.
    Miyashita, K.
    Numata, A.
    Hattori, Y.
    Kawasaki, R.
    Koharazawa, H.
    Fujimaki, K.
    Taguchi, J.
    Fujita, H.
    Sakai, R.
    Fujisawa, S.
    Harano, H.
    Nakajima, H.
    [J]. HAEMATOLOGICA, 2017, 102 : 785 - 785
12345